Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide vs Propranolol in Migraine
NCT05851781Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lacosamide in migraine, sponsored by Kafrelsheikh University. Primary endpoint: Change in migraine days per 28 days. Started Jun 2022; status: completed.
02
Drugs
lacosamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT05851781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05851781.